116,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

Inflammatory breast cancer is the most deadly subtype of breast cancer because it can spread to other organs despite of multidisciplinary approach. However, the molecular characteristic of this aggressive disease is yet to be established. This book is the one of the few textbooks that summarizes the latest information dated to inflammatory breast cancer. The uniqueness of this book is that it has summarized the latest molecular and mechanistic findings, which may lead to novel diagnostic tool or therapeutic approach to fight this deadly disease.

Produktbeschreibung
Inflammatory breast cancer is the most deadly subtype of breast cancer because it can spread to other organs despite of multidisciplinary approach. However, the molecular characteristic of this aggressive disease is yet to be established. This book is the one of the few textbooks that summarizes the latest information dated to inflammatory breast cancer. The uniqueness of this book is that it has summarized the latest molecular and mechanistic findings, which may lead to novel diagnostic tool or therapeutic approach to fight this deadly disease.
Rezensionen
From the reviews:
"This book presents the latest updates on inflammatory breast cancer (IBC), covering its clinical presentation, epidemiology, pathology, basic science, and clinical trials. ... designed for those who manage patients with breast cancer, such as oncologists, nurse practitioners, and medical oncology fellows. Scientists interested in the field of IBC also would find this book useful. ... I would highly recommend this book to anyone involved in the management of patients with inflammatory breast cancer. It is the most comprehensive summary of the disease published to date." (Sara E. Barnato, Doody's Review Service, July, 2012)